Pfizer, BioNTech win pause in patent infringement case from rival Moderna

After nearly two years of legal back and forth, Pfizer and its German partner BioNTech have won a brief reprieve in their patent fight against mRNA rival Moderna.

In a docket entry dated Friday, Massachusetts federal judge Richard G. Stearns granted a stay on the case to provide more time for the Patent Trial and Appeal Board (PTAB) to review challenges against two of the three relevant patents in the litigation.